Imipenem/Cilastatin versus Cefepime as Empiric Monotherapy for Fever in Neutropenic Patients after ematopoietic Stem Cell Transplantation

Objective: To evaluate the potential advantages of imipenem/cilastatin in control of fever in neutro-penic HSCT recipients.Patients and Method: In this single-center study, 111 consecutive febrile episodes in 104 neutropenic HSCT recipients with a mean age of 26 years were randomized to treatment ei...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	C Kani, A Mousavi, M Iravani, K Alimoghaddam, B Bahar, M Jahani, A Ghavamzadeh
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Tehran University of Medical Sciences 2005-06-01
Ráidu:	International Journal of Hematology-Oncology and Stem Cell Research
Fáttát:	Febrile neutropenia Monotherapy Hematopoietic stem cell transplantation Randomized trial
Liŋkkat:	https://ijhoscr.tums.ac.ir/index.php/ijhoscr/article/view/189
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!